Publications of Bernard E Weissman - ReachNC

95 Publications

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

sort by year | cited by

Select All | Save icon

Export

1.
2013

Yasumichi Kuwahara; Darmood Wei; Joel Durand; Bernard E. Weissman

SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters
Molecular Cancer Research. 2013;11(3):251-260.

0
2.
2012

Yasumichi Kuwahara; E. Lorena Mora-Blanco; Fatima Banine; Arlin B. Rogers; Christopher Fletcher; Larry S. Sherman; Charles W. M. Roberts; Bernard E. Weissman

Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development
International Journal of Cancer. 2012.

0
3.
2011

Christopher Bartlett; Tess J. Orvis; Gary S. Rosson; Bernard E. Weissman

BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest
Journal of Cellular Physiology. 2011;226(8):1989-1997.

4
4.
2011

Jessica del Bove; Gary Rosson; Matthew Strobeck; Jianguang Chen; Trevor K. Archer; Weidong Wang; Erik S. Knudsen; Bernard E. Weissman

Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene
Epigenetics. 2011;6(12):1444-1453.

4
5.
2010

Stephanie M. Cohen; Paul D. Chastain II; Gary B. Rosson; Beezly S. Groh; Bernard E. Weissman; David G. Kaufman; Scott J. Bultman

BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression
Nucleic Acids Research. 2010;38(20):6906-6919.

14
6.
2010

Yasumichi Kuwahara; Aubri Charboneau; Erik S. Knudsen; Bernard E. Weissman

Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21^CIP1/WAF1-dependent mechanism
Cancer Research. 2010;70(5):1854-1865.

6
7.
2009

Jessica DelBove; Yasumichi Kuwahara; E. Lorena Mora-Blanco; Virginia Godfrey; William K. Funkhouser; Christopher D. M. Fletcher; Terry Van Dyke; Charles W. M. Roberts; Bernard E. Weissman

Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5+/-;p53+/- mice
Molecular Carcinogenesis. 2009;48(12):1139-1148.

3
8.
2009

Bernard Weissman; Karen E. Knudsen

Hijacking the chromatin remodeling machinery: Impact of SWI/SNF perturbations in cancer
Cancer Research. 2009;69(21):8223-8230.

27
9.
2008

Hui Shen; Nathan Powers; Nitin Saini; Clay E. S. Comstock; Ankur Sharma; Katherine Weaver; Monica P. Revelo; William Gerald; Erin Williams; Walter J. Jessen; et al.

The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer
Cancer Research. 2008;68(24):10154-10162.

16
10.
2007

Jingjing Chai; Xiangdong Lu; Virginia Godfrey; Christopher Fletcher; Charles W.M. Roberts; Terry Van Dyke; Bernard E. Weissman

Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation
Cancer Research. 2007;67(7):3002-3009.

6
11.
2006

Yves A. De Clerck; Bernard E. Weissman; Dihua Yu; Ramon Parsons; Menashe Bar-Eli; Pradip Roy-Burman; Victoria L. Seewaldt; Anne E. Cress; Lucia R. Languino; Surinder K. Batra; et al.

Tumor progression and metastasis from genetic to microenvironmental determinants: A Workshop of the Tumor Progression and Metastasis NIH Study Section in Honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC
Cancer Biology and Therapy. 2006;5(12):1588-1599.

1
12.
2006

Aubri Charboneau; Jingjing Chai; Jennifer Jordan; William Funkhouser; Alexander Judkins; Jaclyn Biegel; Bernard Weissman

P-Akt expression distinguishes two types of malignant rhabdoid tumors
Journal of Cellular Physiology. 2006;209(2):422-427.

2
13.
2005

Jingjing Chai; Aubri L. Charboneau; Bryan L. Betz; Bernard E. Weissman

Loss of the hSNF5 gene concomitantly inactivates p21^CIP/WAF1 and p16^INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells
Cancer Research. 2005;65(22):10192-10198.

44
14.
2005

Gary B. Rosson; Christopher Bartlett; William Reed; B.E. Weissman

BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton
Journal of Cellular Physiology. 2005;205(2):286-294.

21
15.
2005

Fatima Banine; Christopher Bartlett; Ranjaka Gunawardena; Christian Muchardt; Moshe Yaniv; Erik S. Knudsen; Bernard E. Weissman; Larry S. Sherman

SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation
Cancer Research. 2005;65(9):3542-3547.

46
16.
2005

David N. Reisman; Janiece Sciarrotta; Thomas W. Bouldin; Bernard E. Weissman; William K. Funkhouser

The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues
Applied Immunohistochemistry and Molecular Morphology. 2005;13(1):66-74.

27
17.
2005

Kevin A. Link; Craig J. Burd; Erin Williams; Thomas Marshall; Gary Rosson; Erin Henry; Bernard Weissman; Karen E. Knudsen

BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF
Molecular and Cellular Biology. 2005;25(6):2200-2215.

59
18.
2004

Checo J. Rorie; Bernard E. Weissman

The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines
Cancer Research. 2004;64(20):7288-7295.

7
19.
2004

Checo J. Rorie; Venetia D. Thomas; Pengchin Chen; Heather Hanson Pierce; John P. O'Bryan; Bernard E. Weissman

The Ews/Fli-1 Fusion Gene Switches the Differentiation Program of Neuroblastomas to Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors
Cancer Research. 2004;64(4):1266-1277.

39
20.
2003

S.S. Padalecki; K.S. Weldon; X.T. Reveles; C.L. Buller; B. Grubbs; Y. Cui; J.J. Yin; D.C. Hall; B.T. Hummer; B.E. Weissman; et al.

Chromosome 18 suppresses prostate cancer metastases
Urologic Oncology: Seminars and Original Investigations. 2003;21(5):366-373.

6
21.
2003

B. Timothy Hummer; Christopher Bartlett; Erin Henry; Bernard E. Weissman

Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity
Journal of Cellular Physiology. 2003;194(3):289-302.

4
22.
2003

David N. Reisman; Janiece Sciarrotta; Weidong Wang; William K. Funkhouser; Bernard E. Weissman

Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: Correlation with poor prognosis
Cancer Research. 2003;63(3):560-566.

137
23.
2003

Bryan L Betz; Bernard E Weissman

Hybrid capture of putative tumor suppressor genes.
Methods in molecular biology (Clifton, N.J.). 2003;222:365-373.

0
24.
2002

Bryan L. Betz; Matthew W. Strobeck; David N. Reisman; Erik S. Knudsen; Bernard E. Weissman

Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G₁ arrest associated with induction of p16ink4a and activation of RB
Oncogene. 2002;21(34):5193-5203.

96
25.
2002

Matthew W. Strobeck; David N. Reisman; Ranjaka W. Gunawardena; Bryan L. Betz; Steven P. Angus; Karen E. Knudsen; Timothy F. Kowalik; Bernard E. Weissman; Erik S. Knudsen

Compensation of BRG-1 function by Brm. Insight into the role of the core SWI·SNF subunits in retinoblastoma tumor suppressor signaling
Journal of Biological Chemistry. 2002;277(7):4782-4789.

52
26.
2002

David N. Reisman; Matthew W. Strobeck; Bryan L. Betz; Janiece Sciariotta; William Funkhouser Jr.; Christian Murchardt; Moshe Yaniv; Larry S. Sherman; Erik S. Knudsen; et al.

Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: Differential effects on RB-mediated growth arrest vs CD44 expression
Oncogene. 2002;21(8):1196-1207.

74
27.
2002

Jaclyn A. Biegel; Ganjam Kalpana; Erik S. Knudsen; Roger J. Packer; Charles W.M. Roberts; Carol J. Thiele; Bernard Weissman; Malcolm Smith

The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: Meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors
Cancer Research. 2002;62(1):323-328.

93
28.
2001

X.L. Xu; L.C. Wu; F. Du; A. Davis; M. Peyton; Y. Tomizawa; A. Maitra; G. Tomlinson; A.F. Gazdar; B.E. Weissman; et al.

Inactivation of human SRBC, located within the 11p15.5-P15.4 tumor suppressor region, in breast and lung cancers
Cancer Research. 2001;61(21):7943-7949.

55
29.
2001

Matthew W. Strobeck; Marc F. DeCristofaro; Fatima Banine; Bernard E. Weissman; Larry S. Sherman; Erik S. Knudsen

The BRG-1 Subunit of the SWI/SNF Complex Regulates CD44 Expression
Journal of Biological Chemistry. 2001;276(12):9273-9278.

51
30.
2001

Luce Dauphinot; Catherine De Oliveira; Thomas Melot; Nicolas Sevenet; Venetia Thomas; Bernard E. Weissman; Olivier Delattre

Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57^KIP2 and c-Myc expression
Oncogene. 2001;20(25):3258-3265.

107
31.
2001

Marc F. D. Cristofaro; Bryan L. Betz; Checo J. Rorie; David N. Reisman; Weidong Wang; Bernard E. Weissman

Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies
Journal of Cellular Physiology. 2001;186(1):136-145.

106
32.
2000

Raymond V. Merrihew; Rachael D. Cruickshank; Kathleen Conway; Bernard E. Weissman

Altered response of a human squamous cell carcinoma cell line to 1,25-dihydroxyvitamin D₃ after transfer of a normal chromosome 11
Experimental Cell Research. 2000;259(1):191-203.

1
33.
2000

Matthew W. Strobeck; Karen E. Knudsen; Anne F. Fribourg; Marc F. DeCristofaro; Bernard E. Weissman; Anthony N. Imbalzano; Erik S. Knudsen

BRG-1 is required for RB-mediated cell cycle arrest
Proceedings of the National Academy of Sciences of the United States of America. 2000;97(14):7748-7753.

162
34.
2000

Mary E. Miele; Matthew D. Jewett; Steven F. Goldberg; David L. Hyatt; Christina Morelli; Francesca Gualandi; Paola Rimessi; Deana J. Hicks; Bernard E. Weissman; Giuseppi Barbanti-Brodano; et al.

A human melanoma metastasis-suppressor locus maps to 6q16.3-q23
International Journal of Cancer. 2000;86(4):524-528.

41
35.
1999

Marc F. DeCristofaro; Bryan L. Betz; Weidong Wang; Bernard E. Weissman

Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors
Oncogene. 1999;18(52):7559-7565.

58
36.
1999

Marty W. Mayo; Cun-Yu Wang; S. Scott Drouin; Lee V. Madrid; Allen F. Marshall; John C. Reed; Bernard E. Weissman; Albert S. Baldwin

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
EMBO Journal. 1999;18(14):3990-4003.

154
37.
1999

William B. Coleman; Sharon L. Ricketts; Kristen M. Borchert; Sharon C. Presnell; Gwyn L. Esch; Karen D. McCullough; Bernard E. Weissman; Gary J. Smith; Joe W. Grisham

Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines
International Journal of Oncology. 1999;14(5):957-963.

4
38.
1999

Robert J. Isfort; David B. Cody; Glenda J. Lovell; Daniel Gioeli; Bernard E. Weissman; Claus-Jens Doersen

Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids
Molecular Carcinogenesis. 1999;25(1):30-41.

1
39.
1999

Jennifer S. Isaacs; J. Carl Barrett; Bernard E. Weissman

Interference of proteins involved in the cytoplasmic sequestration of p53 with human papillomavirus E6-mediated degradation
Molecular Carcinogenesis. 1999;24(1):70-77.

9
40.
1998

Ande West; Patrick J. Vojta; Danny R. Welch; Bernard E. Weissman

Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1)
Genomics. 1998;54(1):145-148.

71
41.
1998

Jennifer S. Isaacs; Rebecca Hardman; Teresa A. Carman; J. Carl Barrett; Bernard E. Weissman

Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines
Cell Growth and Differentiation. 1998;9(7):545-555.

30
42.
1998

Paul R. Cooper; Nancy J. Smilinich; Colleen D. Day; Norma J. Nowak; Laura H. Reid; R. Scott Pearsall; Mark Reece; Dirk Prawitt; John Landers; David E. Housman; et al.

Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain
Genomics. 1998;49(1):38-51.

51
43.
1998

Karen K. Phillips; Alicia E. White; Deana J. Hicks; Danny R. Welch; J. Carl Barrett; Lisa L. Wei; Bernard E. Weissman

Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the kai-1 protein
Molecular Carcinogenesis. 1998;21(2):111-120.

35
44.
1997

Shyra J. Crider-Miller; Laura H. Reid; Michael J. Higgins; Norma J. Nowak; Thomas B. Shows; P. Andrew Futreal; Bernard E. Weissman

Novel transcribed sequences within the BWS/WT2 region in 11p15.5: Tissue-specific expression correlates with cancer type
Genomics. 1997;46(3):355-363.

8
45.
1997

Xiaohong Yang; Danny R. Welch; Karen K. Phillips; Bernard E. Weissman; Lisa L. Wei

KAII, a putative marker for metastatic potential in human breast cancer
Cancer Letters. 1997;119(2):149-155.

75
46.
1997

Ingrid J. Hall; Dan Gioeli; Bernard E. Weissman; Thea D. Tlsty

Identification of additional complementation groups that regulate genomic instability
Genes Chromosomes and Cancer. 1997;20(2):103-112.

8
47.
1997

Pedro Rodriguez; David Munroe; Dirk Prawitt; Lee Lee Chu; Eva Bric; Jungho Kim; Laura H. Reid; Chris Davies; Hitoshi Nakagama; Ralf Loebbert; et al.

Functional characterization of human nucleosome assembly protein-2 (NAP1L4) suggests a role as a histone chaperone
Genomics. 1997;44(3):253-265.

56
48.
1997

Laura H. Reid; Chris Davies; Paul R. Cooper; Shyra J. Crider-Miller; Sheila N. J. Sait; Norma J. Nowak; Glen Evans; Eric J. Stanbridge; Pieter DeJong; Thomas B. Shows; et al.

A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region
Genomics. 1997;43(3):366-375.

41
49.
1997

Jennifer S. Isaacs; Chia Chiao; B. Alex Merrick; James K. Selkirk; J. Carl Barrett; Bernard E. Weissman

p53-dependent p21 induction following γ-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line
Cancer Research. 1997;57(14):2986-2992.

19
50.
1997

Daniel Gioeli; Kathleen Conway; Bernard E. Weissman

Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures
Cancer Research. 1997;57(6):1157-1165.

10
51.
1997

William B. Coleman; Gwyn L. Esch; Kristen M. Borchert; Karen D. McCullough; Laura H. Reid; Bernard E. Weissman; Gary J. Smith; Joe W. Grisham

Localization of a putative liver tumor suppressor locus to a 950-kb region of human 11p11.2-p12 using rat liver tumor microcell hybrid cell lines
Molecular Carcinogenesis. 1997;19(4):267-272.

9
52.
1997

Jennifer S. Isaacs; Pengchin Chen; Armandina Garza; Marc F. Hansen; J. Carl Barrett; Bernard E. Weissman

Failure of HPV E6 to rapidly degrade p53 in human HeLa x PNET cell hybrids
Oncogene. 1997;14(14):1669-1678.

13
53.
1996

Karen K. Phillips; Danny R. Welch; Mary E. Miele; Jeong-Hyung Lee; Lisa L. Wei; Bernard E. Weissman

Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11
Cancer Research. 1996;56(6):1222-1227.

62
54.
1996

Irene Orlow; Antonio Iavarone; Shyra J. Crider-Miller; Félix Bonilla; Esther Latres; Mong-Hong Lee; William L. Gerald; Joan Massagué; Bernard E. Weissman; Carlos Cordón-Cardó

Cyclin-dependent kinase inhibitor p57^KIP2 in soft tissue sarcomas and Wilms' tumors
Cancer Research. 1996;56(6):1219-1221.

42
55.
1996

Laura Hink Reid; Shyra J. Crider-Miller; Ande West; Mong-Hong Lee; Joan Massagué; Bernard E. Weissman

Genomic organization of the human p57^KIP2 gene and its analysis in the G401 Wilms' tumor assay
Cancer Research. 1996;56(6):1214-1218.

34
56.
1996

Bernard E. Weissman; Daniel Gioeli; Karen Phillips

Identification of tumor suppressor genes by microcell hybridization
Methods: A Companion to Methods in Enzymology. 1996;9(1):38-46.

3
57.
1996

Laura Hink Reid; Ande West; Daniel G. Gioeli; Karen K. Phillips; Kevin F. Kelleher; Diana Araujo; Eric J. Stanbridge; Steven F. Dowdy; Daniela S. Gerhard; Bernard E. Weissman

Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay
Human Molecular Genetics. 1996;5(2):239-247.

48
58.
1996

Jeong-Hyung Lee; Mary E. Miele; Deana J. Hicks; Karen K. Phillips; Jeffery M. Trent; Bernard E. Weissman; Danny R. Welch

KiSS-1, a novel human malignant melanoma metastasis-suppressor gene
Journal of the National Cancer Institute. 1996;88(23):1731-1737.

384
59.
1995

M.L. McMaster; M. Gessler; E.J. Stanbridge; B.E. Weissman

WT1 expression alters tumorigenicity of the G401 kidney-derived cell line
Cell Growth and Differentiation. 1995;6(12):1609-1617.

19
60.
1995

P. Chen; H.-H. Lin; B.E. Weissman

A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer
Oncogene. 1995;10(3):577-586.

11
61.
1995

H. Jiang; J. Lin; Z.-Z. Su; M. Herlyn; R.S. Kerbel; B.E. Weissman; D.R. Welch; P.B. Fisher

The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells
Oncogene. 1995;10(9):1855-1864.

145
62.
1995

W.B. Coleman; K.D. McCullough; G.L. Esch; C.J. Civalier; E. Livanos; B.E. Weissman; J.W. Grisham; G.J. Smith

Suppression of the tumorigenic phenotype of a rat liver epithelial tumor cell line by the p11.2-p12 region of human chromosome 11
Molecular Carcinogenesis. 1995;13(4):220-232.

17
63.
1995

Bernard E. Weissman; Kathleen Conway

Genetic aspects of tumor suppressor genes
Advances in Genome Biology. 1995;3(C):143-162.

0
64.
1994

D.R. Welch; P. Chen; M.E. Miele; C.T. McGary; J.M. Bower; E.J. Stanbridge; B.E. Weissman

Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity
Oncogene. 1994;9(1):255-262.

86
65.
1994

P. Chen; N. Ellmore; B.E. Weissman

Functional evidence for a second tumor suppressor gene on human chromosome 17
Molecular and Cellular Biology. 1994;14(1):534-542.

14
66.
1994

E. Stanbridge; A. Farmer; A. Mills; T. Loftus; D. Kongkasuriyachai; S. Dowdy; B. Weissman

Molecular characterization of QM, a novel gene with properties consistent with tumor suppressor function
Cold Spring Harbor Symposia on Quantitative Biology. 1994;59:573-576.

12
67.
1994

Danny R. Welch; Pengchin Chen; Mary E. Miele; Carl T. McGary; Jill M. Bower; Eric J. Stanbridge; Bernard E. Weissman

Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity
Oncogene. 1994;9(1):XXI-262.

29
68.
1992

W.E. Laug; X.R. Cao; A. T'Ang; S. Pasquale; R. Mundy; M. Coensgen-Luna; B. Weissman

Complex expression of the genes coding for plasminogen activators and their inhibitors in HeLa-smooth muscle cell hybrids.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 1992;3(3):191-197.

5
69.
1992

K. Conway; D. Morgan; K.K. Phillips; S.H. Yuspa; B.E. Weissman

Tumorigenic suppression of a human cutaneous squamous cell carcinoma cell line in the nude mouse skin graft assay
Cancer Research. 1992;52(23):6487-6495.

9
70.
1992

W.E. Loh Jr.; H.J. Scrable; E. Livanos; M.J. Arboleda; W.K. Cavenee; M. Oshimura; B.E. Weissman

Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma
Proceedings of the National Academy of Sciences of the United States of America. 1992;89(5):1755-1759.

53
71.
1992

R. Parshad; F.M. Price; M. Oshimura; J.C. Barrett; H. Satoh; B.E. Weissman; E.J. Stanbridge; K.K. Sanford

Complementation of a DNA repair deficiency in six human tumor cell lines by chromosome 11
Human Genetics. 1992;88(5):524-528.

7
72.
1991

S.F. Dowdy; B.E. Weissman; E.J. Stanbridge

Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma
Journal of Cellular Physiology. 1991;147(2):248-255.

2
73.
1991

S.F. Dowdy; K.-M. Lai; B.E. Weissman; Y. Matsui; B.L.M. Hogan; E.J. Stanbridge

The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells
Nucleic Acids Research. 1991;19(20):5763-5769.

71
74.
1991

S.F. Dowdy; C.L. Fasching; D. Araujo; K.-M. Lai; E. Livanos; B.E. Weissman; E.J. Stanbridge

Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11
Science. 1991;254(5029):293-295.

52
75.
1991

J.K. Makino; B.E. Weissman

Identification of two 36-kD phosphoproteins associated with altered differentiation in retrovirus-transformed Balb/MK-2 mouse keratinocytes
Pathobiology. 1991;59(6):384-390.

0
76.
1990

P. Chen; B.E. Weissman

A complementation analysis of suppression of tumorigenicity in human tumor cell hybrids.
Progress in clinical and biological research. 1990;340 D:13-20.

0
77.
1990

B.E. Weissman

Genetic behaviour of tumorigenicity in human cancer
Cancer Surveys. 1990;9(3):475-485.

2
78.
1989

S.A. Aaronson; J.P. Falco; W.G. Taylor; A.C. Cech; C. Marchese; P.W. Finch; J. Rubin; B.E. Weissman; P.P. Di Fiore

Pathways in which growth factors and oncogenes interact in epithelial cell mitogenic signal transduction
Annals of the New York Academy of Sciences. 1989;567:122-129.

4
79.
1989

B.E. Weissman; M.J. Arboleda; K.A. Kimoto; M.J. MacDonald; R. Ochiai; C.J. Der

Activation of ras oncogenes in chemically transformed BALB/MK-2 mouse keratinocytes
Molecular Carcinogenesis. 1989;2(3):150-158.

4
80.
1988

R.J. Coffey Jr.; C.C. Bascom; N.J. Sipes; R. Graves-Deal; B.E. Weissman; H.L. Moses

Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β
Molecular and Cellular Biology. 1988;8(8):3088-3093.

114
81.
1988

P.P. Di Fiore; J. Falco; I. Borrello; B. Weissman; S.A. Aaronson

The calcium signal for BALB/MK keratinocyte terminal differentiation counteracts epidermal growth factor (EGF) very early in the EGF-induced proliferative pathway
Molecular and Cellular Biology. 1988;8(2):557-563.

4
82.
1988

R.J. Coffey Jr.; N.J. Sipes; C.C. Bascom; R. Graves-Deal; C.Y. Pennington; B.E. Weissman; H.L. Moses

Growth modulation of mouse keratinocytes by transforming growth factors
Cancer Research. 1988;48(6):1596-1602.

52
83.
1988

S.R. Pasquale; G.R. Jones; C.-J. Doersen; B.E. Weissman

Tumorigenicity and oncogene expression in pediatric cancers
Cancer Research. 1988;48(10):2715-2719.

1
84.
1988

J.P. Falco; W.G. Taylor; P.P. Di Fiore; B.E. Weissman; S.A. Aaronson

Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes
Oncogene. 1988;2(6):573-578.

20
85.
1988

C.J. Der; B. Weissman; M.J. MacDonald

Altered guanine nucleotide binding and H-ras transforming and differentiating activities
Oncogene. 1988;3(1):105-112.

20
86.
1987

B.E. Weissman; P.J. Saxon; S.R. Pasquale; G.R. Jones; A.G. Geiser; E.J. Stanbridge

Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression
Science. 1987;236(4798):175-180.

83
87.
1986

G. Vecchio; P.P. Di Fiore; A. Fusco; G. Colletta; B.E. Weissman; S.A. Aaronson

In vitro transformation of epithelial cell by acute retroviruses.
Horizons in biochemistry and biophysics. 1986;8:415-470.

0
88.
1985

B. Weissman; S.A. Aaronson

Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program
Molecular and Cellular Biology. 1985;5(12):3386-3396.

15
89.
1985

B.E. Weissman; C.S. Mark; W.F. Benedict; E.J. Stanbridge

Expression of the N-ras oncogene in tumorigenic and non-tumorigenic HT 1080 fibrosarcoma X normal human fibroblast hybrid cells.
Progress in clinical and biological research. 1985;175:141-149.

1
90.
1984

W.F. Benedict; B.E. Weissman; C. Mark; E.J. Stanbridge

Tumorigenicity of human HT1080 fibrosarcoma x normal fibroblast hybrids: Chromosome dosage dependency
Cancer Research. 1984;44(8):3471-3479.

19
91.
1983

B.E. Weissman; S.A. Aaronson

BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocyte lines
Cell. 1983;32(2):599-606.

50
92.
1983

B.E. Weissman; E.J. Stanbridge

Complementation of the tumorigenic phenotype in human cell hybrids
Journal of the National Cancer Institute. 1983;70(4):667-672.

6
93.
1983

B.E. Weissman; E.J. Stanbridge

Complexity of control of tumorigenic expression in intraspecies hybrids of human SV40-transformed fibroblasts and normal human fibroblast cell lines
Cytogenetics and Cell Genetics. 1983;35(4):263-268.

1
94.
1982

Eric J. Stanbridge; Channing J. Der; Claus-Jens Doersen; Robyn Y. Nishimi; Donna M. Peehl; Bernard E. Weissman; Joyce E. Wilkinson

Human cell hybrids: Analysis of transformation and tumorigenicity
Science. 1982;215(4530):252-259.

61
95.
1980

B. Weissman; E.J. Stanbridge

Characterization of ouabain resistant, hypoxanthine phosphoribosyl transferase deficient human cells and their usefulness as a general method for the production of human cell hybrids
Cytogenetics and Cell Genetics. 1980;28(4):227-239.

11

Bernard E Weissman UNCCH, School of Medicine, Pathology and Laboratory Medicine

Bernard E Weissman

Bernard E Weissman
UNCCH, School of Medicine, Pathology and Laboratory Medicine